Polymorphisms in TLR9 but not in TLR5 increase the risk for duodenal ulcer and alter cytokine expression in the gastric mucosa

Innate Immunity

Volumn 21, Issue 7, 2015, Pages 706-713

  Trejo De La O, Alejandra ^a   Torres, Javier ^b   Sánchez Zauco, Norma ^b,c,d   Pérez Rodríguez, Martha ^e   Camorlinga Ponce, Margarita ^b   Flores Luna, Lourdes ^f   Lazcano Ponce, Eduardo ^f   Maldonado Bernal, Carmen ^c  

^a UNIVERSIDAD LA SALLE   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^e INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^f INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Duodenal ulcer; gastric cancer; Helicobacter pylori; single nucleotide polymorphisms; Toll like receptor 9

Indexed keywords

CYTOKINE; GENOMIC DNA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; ATROPHIC GASTRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DUODENUM ULCER; FEMALE; GASTRIC MUCOSA; GENOTYPE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEXICAN; MIDDLE AGED; PROTEIN EXPRESSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH; STOMACH BIOPSY; STOMACH CANCER; AGED; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER PYLORI; IMMUNOLOGY; METABOLISM;

ADULT; AGED; CYTOKINES; DUODENAL ULCER; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 9;

EID: 84942079640     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425915587130     Document Type: Article

References (29)

1. Yakirevich E, Resnick MN,. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am 2013; 42: 261-284.
2. de Bernard M, Josenhans C,. Pathogenesis of Helicobacter pylori Infection. Helicobacter 2014; 19(Suppl. 1): 11-18.
3. Grivennikov SI, Greten FR, Karin M,. Inmmunity, inflammation, and cancer. Cell 2010; 140: 883-899.
4. Castaño-Rodríguez N, Kaakoush NO, Mitchell HM,. Pattern-recognition receptors and gastric cancer. Front Immunol 2014; 5: 1-19.
5. Smith SM,. Role of Toll-like receptors in Helicobacter pylori infection and immunity. World J Gastrointest Pathophysiol 2014; 5: 133-146.
6. Schmausser B, Andrulis M, Endrich S, et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136: 521-526.
7. Schmausser B, Andrulis M, Endrich S, et al. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 2005; 295: 179-185.
8. Smith MF Jr, Mitchell A, Li G, et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori -induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003; 278: 32552-32560.
9. Torok AM, Bouton AH, Goldberg JB,. Helicobacter pylori induces interleukin-8 secretion by Toll-like receptor 2- and Toll-like receptor 5-dependent and -independent pathways. Infect Immun 2005; 73: 1523-1531.
10. Chang YJ, Wu MS, Lin JT, et al. Helicobacter pylori -Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005; 175: 8242-8252.
11. Wu WK, Sung JJ, Lee CW, et al. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett 2010; 295: 7-16.
12. McLean MH, El-Omar EM,. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014; 11: 664-674.
13. Hold GL, Rabkin CS, Chow WH, et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007; 132: 905-912.
14. Trejo-de la OA, Torres J, Perez-Rodriguez M, et al. TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori -associated gastroduodenal diseases. Clin Immunol 2008; 129: 333-340.
15. Zeng HM, Pan KF, Zhang Y, et al. Genetic variants of toll-like receptor 2 and 5, Helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev 2011; 20: 2594-2602.
16. Ng MT, Van't Hof R, Crockett JC, et al. Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9-1237T/C polymorphism is associated with Helicobacter pylori -induced gastric disease. Infect Immun 2010; 78: 1345-1352.
17. Camorlinga-Ponce M, Torres J, Perez-Perez G, et al. Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children. Am J Gastroenterol 1998; 93: 1264-1270.
18. Nasiri H, Forouzandeh M, Rasaee MJ, et al. Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal 2005; 19: 229-232.
19. Moura SB, Almeida LR, Guerra JB, et al. Toll-like receptor (TLR2, TLR4 and TLR5) gene polymorphisms and Helicobacter pylori infection in children with and without duodenal ulcer. Microbes Infect 2008; 10: 1477-1483.
20. Klimosch SN, Försti A, Eckert J, et al. Funcional TLR5 genetic variants affect human colorectal cancer survival. Cancer Res 2013; 73: 7232-7242.
21. Hold G, Rabkin CS, Gammon MD, et al. CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer Prev 2009; 18: 117-119.
22. Lu P, Sodhi CP, Hackam DJ,. Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis. Pathophysiology 2014; 21: 81-93.
23. Khorramizadeh MR, Hosseinzadeh S, Safavifar F, et al. Interaction of CpG-oligodeoxynucleotides with Toll like receptor 9 induces apoptosis and modulates metaloproteinase-2 activity in human intestinal epithelium. Iran J Allergy Asthma Immunol 2007; 6: 107-114.
24. Hawn TR, Verbon A, Lettinga KD, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003; 198: 1563-1572.
25. Oviedo-Boyso J, Bravo-Patiño A, Baizabal-Aguirre VM,. Collaborative action of Toll-like and NOD-like receptors as modulators of the inflammatory response to pathogenic bacteria. Mediators Inflamm 2014; 2014: 432785-432785.
26. Saraiva M, O'Garra A,. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10: 170-181.
27. Mills KH,. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011; 11: 807-822.
28. Rad R, Brenner L, Krug A, et al. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 2007; 133: 150-163.
29. Benerjee A, Thamphiwatana S, Carmona EM, et al. Deficiency of the myeloid differentiation primary response molecule MyD88 leads to an early and rapid development of Helicobacter -induced gastric malignancy. Infect Immun 2014; 82: 356-363.